VECTOR BIOPHARMA
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.
VECTOR BIOPHARMA
Social Links:
Industry:
Biotechnology Life Science
Founded:
2021-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.vectorbiopharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
Google Font API Amazon HSTS Person Schema Google Google Cloud Gravatar Profiles Cloudflare Amazon S3 Ruby On Rails Token
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
EGenesis
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Transire Bio
Transire Bio offers painless delivery of injectable drugs.
Venneos GmbH
Venneos develops and markets the ‘CAN-Q‘, a silicon-chip-based imaging system for the label-free analysis of biological cells
Investors List
Versant Ventures
Versant Ventures investment in Series A - Vector BioPharma
Official Site Inspections
http://www.vectorbiopharma.com Semrush global rank: 7.86 M Semrush visits lastest month: 685
Unable to get host informations!!!
More informations about "Vector BioPharma"
Versant Ventures Launches Vector BioPharma AG
Where he led a 2,000 member-strong R&D organization. Additionally, he holds Board positions at Phoremost, Mogrify and. at Fraunhofer Institutes Stuttgart and Leipzig. ... About Vector …See details»
Versant Ventures Launches Vector BioPharma AG
Aug 10, 2022 About Vector BioPharma Vector BioPharma is a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery, to improve treatments for patients.See details»
Vector BioPharma: resurrecting adenoviral gene delivery - Nature
Vector Biopharma - PitchBook
Vector Biopharma General Information Description. Operator of a biopharmaceutical company intended to focus on immuno-oncology. The company's system uses engineered adenoviral vectors to achieve cell- and …See details»
Vector BioPharma - VentureRadar
" Vector BioPharma is a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery, to improve treatments for patients. Incorporating cutting-edge …See details»
Vector BioPharma | Portfolio | Versant Ventures
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.See details»
Vector Biopharma AG - Drug pipelines, Patents, Clinical trials
Vector BioPharma, meanwhile, uses virus-like particles to transfer genetic material into the body. Both approaches could be used to treat inherited diseases as well.These methods come with …See details»
Vector BioPharma becomes operational with $30 million series A
Dec 8, 2022 Versant Ventures has launched Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform devoid of viral genes. With a team of …See details»
Vector BioPharma: the future of gene delivery
Nov 16, 2022 Precision gene delivery remains one of the greatest challenges in modern medicine. A Basel-based biopharma company, Vector BioPharma, has accepted the challenge and, with cutting-edge technology from the University …See details»
Vector BioPharma launched by Versant Ventures - Swiss Biotech
Aug 24, 2022 Versant Ventures announced on August 10, 2022, the debut of Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform that is devoid …See details»
Vector: targeted gene delivery with immune-shielded, high …
Aug 11, 2022 Vector BioPharma AG, which debuted Wednesday, is the latest company to emerge from Versant Ventures’ Basel-based incubator Ridgeline, which provides biologists, …See details»
Vector BioPharma and iBET collaborate to develop high …
Jan 10, 2023 Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for …See details»
Series A - Vector BioPharma - 2022-08-10 - Crunchbase
Aug 10, 2022 Vector BioPharma raised $30000000 on 2022-08-10 in Series A. Versant Ventures Versant Ventures caters to the healthcare sector with early and later stage venture, …See details»
Vector BioPharma Launches With Novel Gene Delivery Platform
Aug 10, 2022 Vector BioPharma’s platform aims at three main obstacles faced in the gene delivery field: Tissue-specific delivery of payloads, limitations on the size of genetic cargo, and …See details»
Versant Ventures Launches Vector BioPharma AG
Aug 10, 2022 Incorporating cutting-edge platform technologies, from world-class academic research at the University of Zürich, Vector BioPharma uses engineered virus-like particles to …See details»
Vector BioPharma - startup.ch
Vector BioPharma is a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery, to improve treatments for patients. Incorporating cutting-edge …See details»
Adenovirus-related open positions in Vector BioPharma AG
Vector BioPharma AG, a new Basel-based biotech start-up, is recruiting a large team of scientists to support the development of gene therapy vectors for a range of applications in …See details»
Vector Biopharma closes $30M series A round to support new
Aug 10, 2022 Vector Biopharma AG has secured a $30 million series A funding commitment from founding investor Versant Ventures to take forward a new gene delivery platform …See details»
Versant Ventures Launches Vector BioPharma AG - BioSpace
Aug 10, 2022 BASEL, Switzerland--(BUSINESS WIRE)-- Versant Ventures today announced the debut of Vector BioPharma AG, a biopharmaceutical company developing a precision gene …See details»